OneMedNet regains Nasdaq $1.00 minimum bid price compliance

OneMedNet (ONMD) has regained compliance with Nasdaq's $1.00 minimum bid price requirement. The company met the requirement with 10 consecutive business days of closing prices at or above $1.00, ending October 12, 2026. Nasdaq confirmed compliance on October 13, 2026.

Original reporting
Published Oct 14, 2026, 12:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 12:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
OneMedNet regains Nasdaq $1.00 minimum bid price compliance — source image
Decision brief

The 30-second read

$ONMDNeutralLow
01

Why it matters

The compliance filing removes the immediate threat of delisting, which may stabilize the stock and attract risk‑averse investors.

02

Market read

A primary disclosure of a listing compliance event; relevance is limited to the issuer.

03

What to watch

The underlying share price still hovers near $1, indicating continued liquidity risk if price falls again.

Relevance 5/10Novelty 5/10Timing: post‑market today

Background

OneMedNet was notified of non‑compliance in April 2026 and given a grace period until October 12, 2026. The company met the 10‑day $1.00 price floor and Nasdaq confirmed compliance on October 13, 2026.

Company-level read

Ticker impact

$ONMDNeutralMedium confidence
Context

OneMedNet regained Nasdaq $1.00 minimum bid price compliance after meeting the 10‑day price requirement.

Expected impact

likely modest upside as investors view compliance as a risk mitigation

Evidence & confidence

The filing is a primary disclosure of a compliance event; impact is limited to risk perception rather than fundamentals.

Market effects

Minimal; compliance news is specific to OneMedNet and does not affect the broader healthcare sector.

None; the event is company‑specific.

Low; no broader market impact.

Counterpoint

Some traders may view the compliance regain as a short‑term catalyst and sell into any temporary rally.

Key entities

  • OneMedNet Corp

    Nasdaq‑listed telehealth provider that regained compliance with the $1.00 bid price rule.

Related articles

$ONMDLow

OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook

OneMedNet Corp (ONMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook MINNEAPOLIS, NOVEMBER 6, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provi

$HIMSMed

Why is Hims & Hers Health stock rallying today?

Hims & Hers Health (HIMS) stock rose 5.7% after partnering with Eli Lilly to sell weight-loss drugs Zepbound and Foundayo via its telehealth platform. The deal mirrors a prior agreement with Novo Nordisk, reflecting a shift to FDA-approved obesity medications. Q3 earnings are expected to show $892.88M in revenue. The broader market also gained, with the S&P 500 and Nasdaq rising 0.59% and 1.17%, respectively.